Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Shenzhen Haiwang Biotechnology Co., Ltd. was established in 1992 and is a large pharmaceutical listed company with core business of pharmaceutical research and development, pharmaceutical commerce, and pharmaceutical industry (stock code: 000078). In the past thirty years since its establishment, the company has been based on the forefront of the biopharmaceutical industry, accelerating industry chain integration, and simultaneously promoting endogenous growth and external expansion. Its business performance has maintained stable growth for many consecutive years. Leading Brand Value - The "Haiwang" brand is the most influential brand in the Chinese pharmaceutical and health industry, ranking first in brand value for 17 consecutive years. In 2020, the value of the "Sea King" brand reached 91.568 billion yuan. Outstanding innovation ability - Strong independent technological innovation ability is the core driving force for the rapid development of Sea King Biology. Haiwang Biotechnology leads the international development of pharmaceutical research and development with technological innovation, and forms an independently innovative pharmaceutical research and development system based on national enterprise technology centers and postdoctoral workstations. At present, Haiwang Biotechnology has applied for more than 190 patents and obtained 105 authorized patents. Multiple first class innovative drugs are in different clinical research and development stages and are simultaneously conducting clinical research in the United States, promoting Haiwang's new drugs to enter the international stage. The development of pharmaceutical commercial conglomeration - Haiwang Biotechnology leads the development of pharmaceutical circulation conglomeration through business model innovation. In 2003, Haiwang Biotechnology officially entered the pharmaceutical distribution industry, gradually establishing six regional groups: Haiwang (Shandong) Group, Henan Haiwang Group, Hubei Haiwang Group, Anhui Haiwang Group, Guangdong Haiwang Group, and Heilongjiang Haiwang Group. It established a huge pharmaceutical commercial business network system covering more than 20 provinces, autonomous regions, and municipalities across the country, with over 100 subsidiary companies under its jurisdiction. Relying on the strategic layout of Haiwang Great Health and undergoing several innovative reforms in business models, the sales scale of the commercial system has achieved nearly twenty times growth. In 2019, the sales scale of Haiwang Biological Commercial System reached 46.3 billion yuan. Diversified Product Structure - Haiwang Biotechnology constructs a competitive advantage in the pharmaceutical industry with a diversified and multi-level pharmaceutical product structure. At present, the pharmaceutical industry has more than ten drug formulation forms, nearly 500 drug registration approvals, and over a hundred produced drugs listed in the national essential drug catalog. After nearly 30 years of continuous development and accumulation, Sea King Biological has been in a period of sustained and healthy growth in its pharmaceutical commercial logistics industry, biopharmaceutical industry, and other industries. Sea King Biological adheres to the fundamental purpose of "serving the people's health wholeheartedly" and takes promoting the ecological transformation of China's pharmaceutical and health industry as its own responsibility, launching a new development strategy, Start a new journey for the development of the pharmaceutical and health industry.
Headquarter Shenzhen
Establish Date 12/13/1992
Listed Code 000078.SZ
Listed Date 12/18/1998
Chairman Zhang Simin.
CEO Zhang Feng.
Website www.neptunusbio.com

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial